Despite a shaky knowledge, nearly half of oncologists recommend medical cannabis to their patients, according to a new study.
The survey published in the Journal of Clinical Oncology finds more than half the of oncologists suggesting marijuana, don’t consider themselves knowledgeable to do so.
“Unfortunately, at this time, the evidence base to support medical marijuana’s efficacy in oncology is young,” says Dr. Ilana Braun, a cancer psychiatrist at the Dana-Farber Cancer Institute in Boston, Mass. and the study’s lead author.
The study also found the patient initiated most of the conversations about medical marijuana.
Nearly two-thirds of U.S. states have passed laws allowing for medical marijuana usage, with cancer among the list of medical conditions permitted.
The new survey of 237 oncologists from around the U.S. is the first in decades to ask about views on medical marijuana.
Chivaroli and Associates Insurance Services is a full-service brokerage firm specializing in the custom-design and placement of insurance and alternative risk funding solutions for your healthcare organization.